Abrysvo (Respiratory Syncytial Virus Vaccine Injection) 0.5ml

ABRYSVO is a respiratory syncytial virus (RSV) vaccine injection designed to help protect adults aged 60 and older from RSV-related lower respiratory tract disease. This single-dose 0.5ml formulation is administered intramuscularly to reduce the risk of RSV infection. Seek medical advice for personalized recommendations.

Strength

0.5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

PFIZER US PHARM

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ABRYSVO is used to help prevent respiratory syncytial virus (RSV) infection in adults aged 60 and older. RSV can cause serious lower respiratory tract illness, especially in older adults. The vaccine is designed to stimulate the immune system to recognize and fight RSV. It is not a treatment for active RSV infection.

Side Effects

After receiving ABRYSVO, some individuals may experience mild effects such as pain or redness at the injection site. General effects like fatigue, headache, or muscle pain may also occur. These effects are typically temporary and resolve within a few days. Serious reactions are rare but should be reported to a healthcare provider.

Precautions & Warnings

ABRYSVO should be stored refrigerated between 2°C and 8°C and protected from light. Do not freeze. Before administration, check the vial for particles or discoloration. Discard if the vaccine appears compromised. Inform your healthcare provider about any allergies or medical conditions before receiving this vaccine.

Avoid Interactions

ABRYSVO may interact with immunosuppressive therapies, which could reduce its effectiveness. Limited data exist on co-administration with other vaccines; consult a healthcare provider for guidance. Avoid receiving ABRYSVO if you have a moderate or severe acute illness with or without fever. Always disclose all medications and vaccines to your provider.

Frequently Asked Questions

ABRYSVO is used to help prevent respiratory syncytial virus (RSV) infection in adults aged 60 and older.

ABRYSVO is given as a single 0.5ml injection into the muscle, typically in the upper arm.

Common side effects include pain at the injection site, fatigue, headache, or muscle pain, which are usually mild and temporary.

Individuals with a severe allergic reaction to a previous dose of ABRYSVO or any of its components should avoid this vaccine.

ABRYSVO is approved for adults aged 60 and older, but a healthcare provider should assess individual suitability based on health history.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.